Flagship Acquires Interpace’s Pharma Services Business
Following BroadOak’s growth equity investment in Flagship Biosciences, Flagship Biosciences has acquired Interpace Pharma Solutions, a provider of cytogenetic, molecular pathology, and genomic profiling solutions. Bill Snider and Aaron Fisher are joining the Board of Flagship Biosciences. The full press release is below. BROOMFIELD, Colo., Aug. 31, 2022 /PRNewswire/ — Flagship Biosciences, Inc., a leader […]